In a press release Organovo announced that Barry Michaels will retire as their CFO at the end of Organovo’s fiscal year.
Barry had been announced CFO back in August 2011 and can look back on an outstanding career, which started over 40 years ago. The Company will immediately start the process to identify a successor to ensure a smooth transition.
“I am grateful for the experience I have had at Organovo. It has been a privilege and pleasure to be a member of this team, helping execute an ambitious strategy to change the shape of medical research and practice. I am proud of what we have accomplished together and I look forward to my colleagues continued success and wish them well.”
Keith Murphy, CEO of Organovo:
“As part of the leadership team, Barry has been instrumental in Organovo’s transition from a start-up R&D company into the publicly traded, growing product development company we are today. Barry and his team have done a tremendous job leading Organovo’s financial activities, ensuring our access to capital to fund growth during a pivotal period in our history. At the same time, Barry has also provided guidance to our employees and helped shape a strong culture. His many contributions have better positioned the Company for sustainable growth and success. Although we will be sad to see him leave, all of us wish Barry and his family the best in his retirement.”